Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
1998 1
2000 1
2001 5
2002 5
2003 1
2004 2
2005 4
2006 1
2007 2
2008 7
2009 2
2010 4
2011 4
2012 4
2013 7
2014 7
2015 3
2016 5
2017 3
2018 1
2019 5
2020 6
2021 8
2022 6
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

90 results

Results by year

Filters applied: . Clear all
Page 1
Treatment initiation rates of patients with positive anti-hepatitis C virus results in tertiary hospitals in Turkey.
Çelen MK, Ertürk Şengel B, Kaya Ş, Demirtürk N, Azap A, Pullukçu H, Eroğlu E, Yıldırım F, Barut HŞ, Zerdali E, Sağmak Tartar A, Mete AÖ, Şahin AM, Mutay Suntur B, Sarı ND, Yılmaz E, Candevir A, Şimşek F, İnan D, Akhan S, Asan A, Günal Ö, Ural O, Parlak M, Çabalak M, Nazik S, Hızel K, Kınıklı S, Beştepe Dursun Z, Batırel A, Mermutluoğlu Ç. Çelen MK, et al. Among authors: akhan s. J Infect Dev Ctries. 2024 Mar 31;18(3):441-449. doi: 10.3855/jidc.17910. J Infect Dev Ctries. 2024. PMID: 38635621 Free article.
Comparison of Immunological and Virological Recovery with Rapid, Early, and Late Start of Antiretroviral Treatment in Naive Plwh: Real-World Data.
Sarıgül Yıldırım F, Candevir A, Akhan S, Kaya S, Çabalak M, Ersöz G, İnan D, Ceren N, Karaoğlan İ, Damar Çakırca T, Özer Balin Ş, Alkan S, Kandemir Ö, Üser Ü, Karabay O, Çelen MK. Sarıgül Yıldırım F, et al. Among authors: akhan s. Int J Gen Med. 2023 May 17;16:1867-1877. doi: 10.2147/IJGM.S393370. eCollection 2023. Int J Gen Med. 2023. PMID: 37213471 Free PMC article.
Efficacy, Immunogenicity, and Safety of the Two-Dose Schedules of TURKOVAC versus CoronaVac in Healthy Subjects: A Randomized, Observer-Blinded, Non-Inferiority Phase III Trial.
Tanriover MD, Aydin OA, Guner R, Yildiz O, Celik I, Doganay HL, Kose S, Akhan S, Akalin EH, Sezer Z, Ozdarendeli A, Unal S, On Behalf Of The Turkovac Study Group. Tanriover MD, et al. Among authors: akhan s. Vaccines (Basel). 2022 Nov 4;10(11):1865. doi: 10.3390/vaccines10111865. Vaccines (Basel). 2022. PMID: 36366373 Free PMC article.
Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-19.
Hammond J, Leister-Tebbe H, Gardner A, Abreu P, Bao W, Wisemandle W, Baniecki M, Hendrick VM, Damle B, Simón-Campos A, Pypstra R, Rusnak JM; EPIC-HR Investigators. Hammond J, et al. N Engl J Med. 2022 Apr 14;386(15):1397-1408. doi: 10.1056/NEJMoa2118542. Epub 2022 Feb 16. N Engl J Med. 2022. PMID: 35172054 Free PMC article. Clinical Trial.
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months.
Thomas SJ, Moreira ED Jr, Kitchin N, Absalon J, Gurtman A, Lockhart S, Perez JL, Pérez Marc G, Polack FP, Zerbini C, Bailey R, Swanson KA, Xu X, Roychoudhury S, Koury K, Bouguermouh S, Kalina WV, Cooper D, Frenck RW Jr, Hammitt LL, Türeci Ö, Nell H, Schaefer A, Ünal S, Yang Q, Liberator P, Tresnan DB, Mather S, Dormitzer PR, Şahin U, Gruber WC, Jansen KU; C4591001 Clinical Trial Group. Thomas SJ, et al. N Engl J Med. 2021 Nov 4;385(19):1761-1773. doi: 10.1056/NEJMoa2110345. Epub 2021 Sep 15. N Engl J Med. 2021. PMID: 34525277 Free PMC article. Clinical Trial.
90 results